|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.307
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.217
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.173
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.166
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.149
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.144
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.143
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.133
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.123
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.122
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.119
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.116
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.116
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.116
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.114
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.110
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.110
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.108
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.106
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.102
|
|
|
|
platelet aggregation
|
GO:0070527 |
20 |
0.102
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.088
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.086
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.079
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.078
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.076
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.075
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.074
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.074
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.073
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.073
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.073
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.071
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.071
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.069
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.068
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.068
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.068
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.067
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.067
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.067
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.066
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.066
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.065
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.064
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.059
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.059
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.058
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.057
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.057
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.056
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.056
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.056
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.056
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.055
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.055
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.054
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.054
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.053
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.053
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.052
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.052
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.051
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.051
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.049
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.049
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.049
|
|
|
|
syncytium formation
|
GO:0006949 |
43 |
0.048
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.048
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.048
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.048
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.048
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.047
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.047
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.047
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.046
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.046
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.046
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.045
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.045
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.044
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.044
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.044
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.043
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.043
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.043
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.043
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
68 |
0.042
|
|
|
|
regulation of lymphocyte anergy
|
GO:0002911 |
4 |
0.042
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.042
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.042
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.042
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.041
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.041
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.041
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.040
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.040
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.040
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.040
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.040
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.040
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.039
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.039
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.039
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.038
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.038
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.038
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.038
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.037
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.037
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.037
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.037
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.037
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.036
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.036
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.036
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.035
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.035
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.034
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.034
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.034
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.034
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.034
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.033
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.033
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.033
|
|
|
|
vesicle localization
|
GO:0051648 |
86 |
0.033
|
|
|
|
regulation of t cell anergy
|
GO:0002667 |
4 |
0.033
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.033
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.032
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.032
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.032
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.032
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.032
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.032
|
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.032
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.032
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.032
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.032
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.031
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.031
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.031
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.031
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.031
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.031
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.031
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.030
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.030
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.030
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.030
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.030
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.030
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.030
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.030
|
|
|
|
regulation of phospholipase c activity
|
GO:1900274 |
3 |
0.029
|
|
|
|
positive t cell selection
|
GO:0043368 |
23 |
0.029
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.029
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.029
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.029
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.029
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.028
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.028
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.028
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.028
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.028
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.028
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.028
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.028
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.028
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.028
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.028
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.027
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.027
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.027
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.027
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.027
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.027
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.027
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.027
|
|
|
|
regulation of calcium mediated signaling
|
GO:0050848 |
19 |
0.027
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.027
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.026
|
|
|
|
thymic t cell selection
|
GO:0045061 |
22 |
0.026
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.026
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.026
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.026
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.026
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.026
|
|
|
|
positive regulation of lymphocyte anergy
|
GO:0002913 |
4 |
0.026
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.026
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.026
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.026
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.026
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.026
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.026
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.025
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.025
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.025
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.025
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.025
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.025
|
|
|
|
positive regulation of t cell anergy
|
GO:0002669 |
4 |
0.025
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.025
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.025
|
|
|
|
t cell anergy
|
GO:0002870 |
4 |
0.025
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.025
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.025
|
|
|
|
positive regulation of cytokine biosynthetic process
|
GO:0042108 |
40 |
0.025
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.024
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.024
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.024
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.024
|
|
|
|
lymphocyte anergy
|
GO:0002249 |
4 |
0.024
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.024
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.024
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.024
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.024
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.024
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.023
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.023
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.023
|
|
|
|
interleukin 4 production
|
GO:0032633 |
24 |
0.023
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.023
|
|
|
|
myeloid cell activation involved in immune response
|
GO:0002275 |
34 |
0.023
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.023
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.023
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.023
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.023
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.023
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.023
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.023
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.023
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.023
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.023
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.022
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.022
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.022
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.022
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.022
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.022
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.022
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.022
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.022
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.022
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.022
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.022
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.022
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.022
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.022
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.021
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.021
|
|
|
|
homotypic cell cell adhesion
|
GO:0034109 |
28 |
0.021
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.021
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.021
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.021
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.021
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.021
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.021
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.021
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.021
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.021
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.021
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.020
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.020
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.020
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.020
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.020
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.020
|
|
|
|
leukocyte cell cell adhesion
|
GO:0007159 |
14 |
0.020
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.020
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.020
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.020
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.020
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.020
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.019
|
|
|
|
monocyte extravasation
|
GO:0035696 |
2 |
0.019
|
|
|
|
t cell selection
|
GO:0045058 |
34 |
0.019
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.019
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.019
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.019
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.019
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.019
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.019
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.019
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.019
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.019
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.019
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.019
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.019
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.019
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.019
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.019
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.018
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.018
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.018
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.018
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.018
|
|
|
|
regulation of erythrocyte differentiation
|
GO:0045646 |
23 |
0.018
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.018
|
|
|
|
cellular extravasation
|
GO:0045123 |
17 |
0.018
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.018
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.018
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.018
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.018
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.018
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.018
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.018
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.018
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.018
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.018
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.018
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.018
|
|
|
|
auditory receptor cell differentiation
|
GO:0042491 |
37 |
0.017
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.017
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.017
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.017
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.017
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.017
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.017
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.017
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.017
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.017
|
|
|
|
regulation of actin polymerization or depolymerization
|
GO:0008064 |
45 |
0.017
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.017
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.017
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.017
|
|
|
|
t cell receptor signaling pathway
|
GO:0050852 |
46 |
0.017
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.017
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.017
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.017
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.017
|
|
|
|
interleukin 2 production
|
GO:0032623 |
33 |
0.017
|
|
|
|
cellular response to prostaglandin stimulus
|
GO:0071379 |
2 |
0.017
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.017
|
|
|
|
cofactor transport
|
GO:0051181 |
4 |
0.017
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.017
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.017
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.016
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.016
|
|
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
41 |
0.016
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.016
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
42 |
0.016
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.016
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.016
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
51 |
0.016
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.016
|
|
|
|
b cell mediated immunity
|
GO:0019724 |
71 |
0.016
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.016
|
|
|
|
positive regulation of synaptic plasticity
|
GO:0031915 |
4 |
0.016
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.016
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.016
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.016
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.016
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.016
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.016
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.016
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.015
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.015
|
|
|
|
regulation of toll like receptor 4 signaling pathway
|
GO:0034143 |
4 |
0.015
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.015
|
|
|
|
phagolysosome assembly
|
GO:0001845 |
3 |
0.015
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.015
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.015
|
|
|
|
interleukin 1 alpha secretion
|
GO:0050703 |
3 |
0.015
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.015
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.015
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.015
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.015
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.015
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.015
|
|
|
|
positive regulation of phospholipase c activity
|
GO:0010863 |
2 |
0.015
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.015
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.015
|
|
|
|
regulation of monocyte extravasation
|
GO:2000437 |
2 |
0.015
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.015
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.015
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.015
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.015
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.015
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.015
|
|
|
|
cd8 positive alpha beta t cell extravasation
|
GO:0035697 |
3 |
0.015
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.015
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.014
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.014
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.014
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.014
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.014
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.014
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.014
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.014
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.014
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.014
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.014
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.014
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.014
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.014
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.014
|
|
|
|
regulation of interleukin 1 alpha secretion
|
GO:0050705 |
3 |
0.014
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.014
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.014
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.014
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.014
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.014
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.014
|
|
|
|
substrate adhesion dependent cell spreading
|
GO:0034446 |
30 |
0.014
|
|
|
|
ceramide metabolic process
|
GO:0006672 |
31 |
0.014
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.013
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.013
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.013
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.013
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.013
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.013
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.013
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.013
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.013
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.013
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.013
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.013
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.013
|
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.013
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.013
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.013
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.013
|
|
|
|
alpha beta t cell proliferation
|
GO:0046633 |
21 |
0.013
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.013
|
|
|
|
mast cell degranulation
|
GO:0043303 |
19 |
0.013
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.013
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.013
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.013
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.013
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.013
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.013
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.013
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.013
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
50 |
0.013
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.013
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.013
|
|
|
|
regulation of systemic arterial blood pressure by chemoreceptor signaling
|
GO:0001979 |
1 |
0.013
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.013
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.013
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.013
|
|
|
|
hematopoietic stem cell migration
|
GO:0035701 |
1 |
0.013
|
|
|
|
tolerance induction to self antigen
|
GO:0002513 |
4 |
0.013
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.013
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.013
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.012
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.012
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.012
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.012
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.012
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.012
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.012
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.012
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.012
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.012
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.012
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.012
|
|
|
|
negative regulation of myeloid dendritic cell activation
|
GO:0030886 |
3 |
0.012
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.012
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.012
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.012
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.012
|
|
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
49 |
0.012
|
|
|
|
vacuole organization
|
GO:0007033 |
38 |
0.012
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.012
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.012
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.012
|
|
|
|
positive regulation of exocytosis
|
GO:0045921 |
20 |
0.012
|
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.012
|
|
|
|
response to prostaglandin d
|
GO:0071798 |
1 |
0.012
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.012
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.012
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.012
|
|
|
|
regulation of myeloid dendritic cell activation
|
GO:0030885 |
5 |
0.012
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.012
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.012
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.012
|
|
|
|
associative learning
|
GO:0008306 |
61 |
0.012
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.012
|
|
|
|
positive regulation of calcium mediated signaling
|
GO:0050850 |
15 |
0.012
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.012
|
|
|
|
regulation of t cell mediated cytotoxicity
|
GO:0001914 |
18 |
0.012
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.012
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.012
|
|
|
|
phospholipid transfer to membrane
|
GO:0006649 |
2 |
0.012
|
|
|
|
dorsal ventral axon guidance
|
GO:0033563 |
3 |
0.012
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.012
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.012
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.012
|
|
|
|
mast cell activation
|
GO:0045576 |
27 |
0.011
|
|
